These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 24471427)
1. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427 [TBL] [Abstract][Full Text] [Related]
2. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation. Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225 [TBL] [Abstract][Full Text] [Related]
3. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients. Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659 [TBL] [Abstract][Full Text] [Related]
4. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation. Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723 [TBL] [Abstract][Full Text] [Related]
6. Role of defensins in the pathogenesis of chronic lung allograft rejection. Tiriveedhi V; Banan B; Deepti S; Nataraju A; Hachem R; Trulock E; Alexander PG; Thalachallour M Hum Immunol; 2014 Apr; 75(4):370-7. PubMed ID: 24380698 [TBL] [Abstract][Full Text] [Related]
7. Bronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression. Stober VP; Szczesniak C; Childress Q; Heise RL; Bortner C; Hollingsworth JW; Neuringer IP; Palmer SM; Garantziotis S Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L1045-55. PubMed ID: 24748604 [TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419 [TBL] [Abstract][Full Text] [Related]
9. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation. White SR; Floreth T; Liao C; Bhorade SM PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264 [TBL] [Abstract][Full Text] [Related]
10. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701 [TBL] [Abstract][Full Text] [Related]
12. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Berlin A; Ross DJ; Kunkel SL; Charo IF; Strieter RM J Clin Invest; 2001 Aug; 108(4):547-56. PubMed ID: 11518728 [TBL] [Abstract][Full Text] [Related]
13. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction. Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576 [TBL] [Abstract][Full Text] [Related]
14. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. Hardison MT; Galin FS; Calderon CE; Djekic UV; Parker SB; Wille KM; Jackson PL; Oster RA; Young KR; Blalock JE; Gaggar A J Immunol; 2009 Apr; 182(7):4423-31. PubMed ID: 19299743 [TBL] [Abstract][Full Text] [Related]
15. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients. Nord M; Schubert K; Cassel TN; Andersson O; Riise GC Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419 [TBL] [Abstract][Full Text] [Related]
16. Lung T-Cell Profile Alterations are Associated with Bronchiolitis Obliterans Syndrome in Cystic Fibrosis Lung Transplant Recipients. Hayes D; Harhay MO; Nicol KK; Liyanage NPM; Keller BC; Robinson RT Lung; 2020 Feb; 198(1):157-161. PubMed ID: 31807920 [TBL] [Abstract][Full Text] [Related]
17. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341 [TBL] [Abstract][Full Text] [Related]
18. Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection. Gunasekaran M; Sharma M; Hachem R; Bremner R; Smith MA; Mohanakumar T J Immunol; 2018 Apr; 200(8):2535-2541. PubMed ID: 29491008 [TBL] [Abstract][Full Text] [Related]
19. A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Tiriveedhi V; Angaswamy N; Brand D; Weber J; Gelman AG; Hachem R; Trulock EP; Meyers B; Patterson G; Mohanakumar T Clin Exp Immunol; 2012 Jan; 167(1):158-68. PubMed ID: 22132895 [TBL] [Abstract][Full Text] [Related]
20. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Zheng L; Walters EH; Ward C; Wang N; Orsida B; Whitford H; Williams TJ; Kotsimbos T; Snell GI Thorax; 2000 Jan; 55(1):53-9. PubMed ID: 10607802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]